APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Medical Cannabidiol

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pet Medical Cannabidiol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 July 2026190 pages

Choose your research edition.

Industry ResearchPet Medical Cannabidiol Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Medical Cannabidiol Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Pet Medical Cannabidiol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Medical Cannabidiol Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Medical Cannabidiol Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Pet Medical Cannabidiol market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pet Medical Cannabidiol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pet Medical Cannabidiol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Medical Cannabidiol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pet Medical Cannabidiol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pet Medical Cannabidiol include Canna-Pet, Holistic Hound, BATCH, Choom Holdings, Receptra Naturals, Curaleaf, Trulieve Cannabis, Pure Spectrum and Cannabis Strategies Acquisition, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pet Medical Cannabidiol market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pet Medical Cannabidiol and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pet Medical Cannabidiol sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pet Medical Cannabidiol market size, projected growth trends, production technologies, key applications, and end-use industries.

Pet Medical Cannabidiol Segment by Company

Canna-Pet

Holistic Hound

BATCH

Choom Holdings

Receptra Naturals

Curaleaf

Trulieve Cannabis

Pure Spectrum

Cannabis Strategies Acquisition

Pet Releaf

Diamond CBD

PotNetwork Holdings

Kat's Naturals

Bluebird Botanicals

Pet Medical Cannabidiol Segment by Type

Oral Cannabidiol

Topical Cannabidiol

Pet Medical Cannabidiol Segment by Application

Anaesthetization

Stimulate Appetite

Relieve Anxiety

Others

Pet Medical Cannabidiol Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Medical Cannabidiol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Medical Cannabidiol and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Medical Cannabidiol.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pet Medical Cannabidiol market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pet Medical Cannabidiol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pet Medical Cannabidiol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pet Medical Cannabidiol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pet Medical Cannabidiol Industry Trends Table 2. Pet Medical Cannabidiol Industry Drivers Table 3. Pet Medical Cannabidiol Industry Opportunities and Challenges Table 4. Pet Medical Cannabidiol Industry Restraints Table 5. Global Pet Medical Cannabidiol Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pet Medical Cannabidiol Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pet Medical Cannabidiol Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Pet Medical Cannabidiol Sales Market Share by Manufacturers Table 9. Global Pet Medical Cannabidiol Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Pet Medical Cannabidiol Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pet Medical Cannabidiol Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pet Medical Cannabidiol Manufacturers, Product Type & Application Table 13. Global Pet Medical Cannabidiol Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pet Medical Cannabidiol by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Oral Cannabidiol Table 17. Major Manufacturers of Topical Cannabidiol Table 18. Global Pet Medical Cannabidiol Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Pet Medical Cannabidiol Sales by Type (2021-2026) & (k units) Table 20. Global Pet Medical Cannabidiol Sales by Type (2027-2032) & (k units) Table 21. Global Pet Medical Cannabidiol Sales Market Share by Type (2021-2026) Table 22. Global Pet Medical Cannabidiol Sales Market Share by Type (2027-2032) Table 23. Global Pet Medical Cannabidiol Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Pet Medical Cannabidiol Revenue by Type (2021-2026) & (k units) Table 25. Global Pet Medical Cannabidiol Revenue by Type (2027-2032) & (k units) Table 26. Global Pet Medical Cannabidiol Revenue Market Share by Type (2021-2026) Table 27. Global Pet Medical Cannabidiol Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Anaesthetization Table 29. Major Manufacturers of Stimulate Appetite Table 30. Major Manufacturers of Relieve Anxiety Table 31. Major Manufacturers of Others Table 32. Global Pet Medical Cannabidiol Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Pet Medical Cannabidiol Sales by Application (2021-2026) & (k units) Table 34. Global Pet Medical Cannabidiol Sales by Application (2027-2032) & (k units) Table 35. Global Pet Medical Cannabidiol Sales Market Share by Application (2021-2026) Table 36. Global Pet Medical Cannabidiol Sales Market Share by Application (2027-2032) Table 37. Global Pet Medical Cannabidiol Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Pet Medical Cannabidiol Revenue by Application (2021-2026) & (k units) Table 39. Global Pet Medical Cannabidiol Revenue by Application (2027-2032) & (k units) Table 40. Global Pet Medical Cannabidiol Revenue Market Share by Application (2021-2026) Table 41. Global Pet Medical Cannabidiol Revenue Market Share by Application (2027-2032) Table 42. Global Pet Medical Cannabidiol Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Pet Medical Cannabidiol Sales by Region (2021-2026) & (k units) Table 44. Global Pet Medical Cannabidiol Sales Market Share by Region (2021-2026) Table 45. Global Pet Medical Cannabidiol Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Pet Medical Cannabidiol Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Pet Medical Cannabidiol Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Pet Medical Cannabidiol Sales by Country (2021-2026) & (k units) Table 49. North America Pet Medical Cannabidiol Sales by Country (2027-2032) & (k units) Table 50. Europe Pet Medical Cannabidiol Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Pet Medical Cannabidiol Sales by Country (2021-2026) & (k units) Table 52. Europe Pet Medical Cannabidiol Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Pet Medical Cannabidiol Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Pet Medical Cannabidiol Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Pet Medical Cannabidiol Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Pet Medical Cannabidiol Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Pet Medical Cannabidiol Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Pet Medical Cannabidiol Sales by Country (2027-2032) & (k units) Table 59. Global Pet Medical Cannabidiol Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Pet Medical Cannabidiol Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Pet Medical Cannabidiol Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Pet Medical Cannabidiol Revenue Market Share by Region (2021-2026) Table 63. Global Pet Medical Cannabidiol Revenue Market Share by Region (2027-2032) Table 64. Canna-Pet Company Information Table 65. Canna-Pet Business Overview Table 66. Canna-Pet Pet Medical Cannabidiol Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Canna-Pet Pet Medical Cannabidiol Product Portfolio Table 68. Canna-Pet Recent Development Table 69. Holistic Hound Company Information Table 70. Holistic Hound Business Overview Table 71. Holistic Hound Pet Medical Cannabidiol Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Holistic Hound Pet Medical Cannabidiol Product Portfolio Table 73. Holistic Hound Recent Development Table 74. BATCH Company Information Table 75. BATCH Business Overview Table 76. BATCH Pet Medical Cannabidiol Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. BATCH Pet Medical Cannabidiol Product Portfolio Table 78. BATCH Recent Development Table 79. Choom Holdings Company Information Table 80. Choom Holdings Business Overview Table 81. Choom Holdings Pet Medical Cannabidiol Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Choom Holdings Pet Medical Cannabidiol Product Portfolio Table 83. Choom Holdings Recent Development Table 84. Receptra Naturals Company Information Table 85. Receptra Naturals Business Overview Table 86. Receptra Naturals Pet Medical Cannabidiol Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Receptra Naturals Pet Medical Cannabidiol Product Portfolio Table 88. Receptra Naturals Recent Development Table 89. Curaleaf Company Information Table 90. Curaleaf Business Overview Table 91. Curaleaf Pet Medical Cannabidiol Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Curaleaf Pet Medical Cannabidiol Product Portfolio Table 93. Curaleaf Recent Development Table 94. Trulieve Cannabis Company Information Table 95. Trulieve Cannabis Business Overview Table 96. Trulieve Cannabis Pet Medical Cannabidiol Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Trulieve Cannabis Pet Medical Cannabidiol Product Portfolio Table 98. Trulieve Cannabis Recent Development Table 99. Pure Spectrum Company Information Table 100. Pure Spectrum Business Overview Table 101. Pure Spectrum Pet Medical Cannabidiol Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Pure Spectrum Pet Medical Cannabidiol Product Portfolio Table 103. Pure Spectrum Recent Development Table 104. Cannabis Strategies Acquisition Company Information Table 105. Cannabis Strategies Acquisition Business Overview Table 106. Cannabis Strategies Acquisition Pet Medical Cannabidiol Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Cannabis Strategies Acquisition Pet Medical Cannabidiol Product Portfolio Table 108. Cannabis Strategies Acquisition Recent Development Table 109. Pet Releaf Company Information Table 110. Pet Releaf Business Overview Table 111. Pet Releaf Pet Medical Cannabidiol Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Pet Releaf Pet Medical Cannabidiol Product Portfolio Table 113. Pet Releaf Recent Development Table 114. Diamond CBD Company Information Table 115. Diamond CBD Business Overview Table 116. Diamond CBD Pet Medical Cannabidiol Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Diamond CBD Pet Medical Cannabidiol Product Portfolio Table 118. Diamond CBD Recent Development Table 119. PotNetwork Holdings Company Information Table 120. PotNetwork Holdings Business Overview Table 121. PotNetwork Holdings Pet Medical Cannabidiol Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. PotNetwork Holdings Pet Medical Cannabidiol Product Portfolio Table 123. PotNetwork Holdings Recent Development Table 124. Kat's Naturals Company Information Table 125. Kat's Naturals Business Overview Table 126. Kat's Naturals Pet Medical Cannabidiol Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Kat's Naturals Pet Medical Cannabidiol Product Portfolio Table 128. Kat's Naturals Recent Development Table 129. Bluebird Botanicals Company Information Table 130. Bluebird Botanicals Business Overview Table 131. Bluebird Botanicals Pet Medical Cannabidiol Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Bluebird Botanicals Pet Medical Cannabidiol Product Portfolio Table 133. Bluebird Botanicals Recent Development Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. Pet Medical Cannabidiol Distributors List Table 137. Pet Medical Cannabidiol Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Pet Medical Cannabidiol Product Image Figure 2. Global Pet Medical Cannabidiol Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Medical Cannabidiol Market Size (2021-2032) & (US$ Million) Figure 4. Global Pet Medical Cannabidiol Sales (2021-2032) & (k units) Figure 5. Global Pet Medical Cannabidiol Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pet Medical Cannabidiol Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Oral Cannabidiol Image Figure 9. Topical Cannabidiol Image Figure 10. Global Pet Medical Cannabidiol Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Pet Medical Cannabidiol Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Pet Medical Cannabidiol Sales Market Share by Type (2021-2032) Figure 13. Global Pet Medical Cannabidiol Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Pet Medical Cannabidiol Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Pet Medical Cannabidiol Revenue Market Share by Type (2021-2032) Figure 16. Anaesthetization Image Figure 17. Stimulate Appetite Image Figure 18. Relieve Anxiety Image Figure 19. Others Image Figure 20. Global Pet Medical Cannabidiol Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Pet Medical Cannabidiol Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Pet Medical Cannabidiol Sales Market Share by Application (2021-2032) Figure 23. Global Pet Medical Cannabidiol Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Pet Medical Cannabidiol Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Pet Medical Cannabidiol Revenue Market Share by Application (2021-2032) Figure 26. North America Pet Medical Cannabidiol Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Pet Medical Cannabidiol Sales Market Share by Country (2021-2032) Figure 28. U.S. Pet Medical Cannabidiol Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Pet Medical Cannabidiol Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Pet Medical Cannabidiol Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Pet Medical Cannabidiol Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Pet Medical Cannabidiol Sales Market Share by Country (2021-2032) Figure 33. Germany Pet Medical Cannabidiol Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Pet Medical Cannabidiol Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Pet Medical Cannabidiol Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Pet Medical Cannabidiol Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Pet Medical Cannabidiol Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Pet Medical Cannabidiol Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Pet Medical Cannabidiol Sales Market Share by Country (2021-2032) Figure 40. China Pet Medical Cannabidiol Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Pet Medical Cannabidiol Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Pet Medical Cannabidiol Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Pet Medical Cannabidiol Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Pet Medical Cannabidiol Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Pet Medical Cannabidiol Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Pet Medical Cannabidiol Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Pet Medical Cannabidiol Sales Market Share by Country (2021-2032) Figure 48. Brazil Pet Medical Cannabidiol Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Pet Medical Cannabidiol Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Pet Medical Cannabidiol Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Pet Medical Cannabidiol Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Pet Medical Cannabidiol Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Pet Medical Cannabidiol Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Pet Medical Cannabidiol Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Pet Medical Cannabidiol Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Pet Medical Cannabidiol Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Pet Medical Cannabidiol Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Figure 59. North America Pet Medical Cannabidiol Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Figure 61. Europe Pet Medical Cannabidiol Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Pet Medical Cannabidiol Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Pet Medical Cannabidiol Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Pet Medical Cannabidiol Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Pet Medical Cannabidiol Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Cannabidiol
  • Topical Cannabidiol
Applications
  • Anaesthetization
  • Stimulate Appetite
  • Relieve Anxiety
  • Others
Companies covered
  • Canna-Pet
  • Holistic Hound
  • BATCH
  • Choom Holdings
  • Receptra Naturals
  • Curaleaf
  • Trulieve Cannabis
  • Pure Spectrum
  • Cannabis Strategies Acquisition
  • Pet Releaf
  • Diamond CBD
  • PotNetwork Holdings
  • Kat's Naturals
  • Bluebird Botanicals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pet Medical Cannabidiol Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pet Medical Cannabidiol Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pet Medical Cannabidiol Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pet Medical Cannabidiol Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pet Medical Cannabidiol Market Dynamics
  1. 2.1 Pet Medical Cannabidiol Industry Trends
  2. 2.2 Pet Medical Cannabidiol Industry Drivers
  3. 2.3 Pet Medical Cannabidiol Industry Opportunities and Challenges
  4. 2.4 Pet Medical Cannabidiol Industry Restraints
3 Pet Medical Cannabidiol Market by Manufacturers
  1. 3.1 Global Pet Medical Cannabidiol Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pet Medical Cannabidiol Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pet Medical Cannabidiol Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pet Medical Cannabidiol Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pet Medical Cannabidiol Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pet Medical Cannabidiol Manufacturers, Product Type & Application
  7. 3.7 Global Pet Medical Cannabidiol Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pet Medical Cannabidiol Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pet Medical Cannabidiol Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pet Medical Cannabidiol Tier 1, Tier 2, and Tier 3
4 Pet Medical Cannabidiol Market by Type
  1. 4.1 Pet Medical Cannabidiol Type Introduction
  2. 4.1.1 Oral Cannabidiol
  3. 4.1.2 Topical Cannabidiol
  4. 4.2 Global Pet Medical Cannabidiol Sales by Type
  5. 4.2.1 Global Pet Medical Cannabidiol Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pet Medical Cannabidiol Sales by Type (2021-2032)
  7. 4.2.3 Global Pet Medical Cannabidiol Sales Market Share by Type (2021-2032)
  8. 4.3 Global Pet Medical Cannabidiol Revenue by Type
  9. 4.3.1 Global Pet Medical Cannabidiol Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pet Medical Cannabidiol Revenue by Type (2021-2032)
  11. 4.3.3 Global Pet Medical Cannabidiol Revenue Market Share by Type (2021-2032)
5 Pet Medical Cannabidiol Market by Application
  1. 5.1 Pet Medical Cannabidiol Application Introduction
  2. 5.1.1 Anaesthetization
  3. 5.1.2 Stimulate Appetite
  4. 5.1.3 Relieve Anxiety
  5. 5.1.4 Others
  6. 5.2 Global Pet Medical Cannabidiol Sales by Application
  7. 5.2.1 Global Pet Medical Cannabidiol Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pet Medical Cannabidiol Sales by Application (2021-2032)
  9. 5.2.3 Global Pet Medical Cannabidiol Sales Market Share by Application (2021-2032)
  10. 5.3 Global Pet Medical Cannabidiol Revenue by Application
  11. 5.3.1 Global Pet Medical Cannabidiol Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Pet Medical Cannabidiol Revenue by Application (2021-2032)
  13. 5.3.3 Global Pet Medical Cannabidiol Revenue Market Share by Application (2021-2032)
6 Global Pet Medical Cannabidiol Sales by Region
  1. 6.1 Global Pet Medical Cannabidiol Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pet Medical Cannabidiol Sales by Region (2021-2032)
  3. 6.2.1 Global Pet Medical Cannabidiol Sales by Region (2021-2026)
  4. 6.2.2 Global Pet Medical Cannabidiol Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pet Medical Cannabidiol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pet Medical Cannabidiol Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pet Medical Cannabidiol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pet Medical Cannabidiol Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pet Medical Cannabidiol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pet Medical Cannabidiol Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pet Medical Cannabidiol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pet Medical Cannabidiol Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pet Medical Cannabidiol Revenue by Region
  1. 7.1 Global Pet Medical Cannabidiol Revenue by Region
  2. 7.1.1 Global Pet Medical Cannabidiol Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pet Medical Cannabidiol Revenue by Region (2021-2026)
  4. 7.1.3 Global Pet Medical Cannabidiol Revenue by Region (2027-2032)
  5. 7.1.4 Global Pet Medical Cannabidiol Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pet Medical Cannabidiol Revenue (2021-2032)
  8. 7.2.2 North America Pet Medical Cannabidiol Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pet Medical Cannabidiol Revenue (2021-2032)
  11. 7.3.2 Europe Pet Medical Cannabidiol Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pet Medical Cannabidiol Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pet Medical Cannabidiol Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pet Medical Cannabidiol Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pet Medical Cannabidiol Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Canna-Pet
  2. 8.1.1 Canna-Pet Company Information
  3. 8.1.2 Canna-Pet Business Overview
  4. 8.1.3 Canna-Pet Pet Medical Cannabidiol Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Canna-Pet Pet Medical Cannabidiol Product Portfolio
  6. 8.1.5 Canna-Pet Recent Developments
  7. 8.2 Holistic Hound
  8. 8.2.1 Holistic Hound Company Information
  9. 8.2.2 Holistic Hound Business Overview
  10. 8.2.3 Holistic Hound Pet Medical Cannabidiol Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Holistic Hound Pet Medical Cannabidiol Product Portfolio
  12. 8.2.5 Holistic Hound Recent Developments
  13. 8.3 BATCH
  14. 8.3.1 BATCH Company Information
  15. 8.3.2 BATCH Business Overview
  16. 8.3.3 BATCH Pet Medical Cannabidiol Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BATCH Pet Medical Cannabidiol Product Portfolio
  18. 8.3.5 BATCH Recent Developments
  19. 8.4 Choom Holdings
  20. 8.4.1 Choom Holdings Company Information
  21. 8.4.2 Choom Holdings Business Overview
  22. 8.4.3 Choom Holdings Pet Medical Cannabidiol Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Choom Holdings Pet Medical Cannabidiol Product Portfolio
  24. 8.4.5 Choom Holdings Recent Developments
  25. 8.5 Receptra Naturals
  26. 8.5.1 Receptra Naturals Company Information
  27. 8.5.2 Receptra Naturals Business Overview
  28. 8.5.3 Receptra Naturals Pet Medical Cannabidiol Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Receptra Naturals Pet Medical Cannabidiol Product Portfolio
  30. 8.5.5 Receptra Naturals Recent Developments
  31. 8.6 Curaleaf
  32. 8.6.1 Curaleaf Company Information
  33. 8.6.2 Curaleaf Business Overview
  34. 8.6.3 Curaleaf Pet Medical Cannabidiol Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Curaleaf Pet Medical Cannabidiol Product Portfolio
  36. 8.6.5 Curaleaf Recent Developments
  37. 8.7 Trulieve Cannabis
  38. 8.7.1 Trulieve Cannabis Company Information
  39. 8.7.2 Trulieve Cannabis Business Overview
  40. 8.7.3 Trulieve Cannabis Pet Medical Cannabidiol Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Trulieve Cannabis Pet Medical Cannabidiol Product Portfolio
  42. 8.7.5 Trulieve Cannabis Recent Developments
  43. 8.8 Pure Spectrum
  44. 8.8.1 Pure Spectrum Company Information
  45. 8.8.2 Pure Spectrum Business Overview
  46. 8.8.3 Pure Spectrum Pet Medical Cannabidiol Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pure Spectrum Pet Medical Cannabidiol Product Portfolio
  48. 8.8.5 Pure Spectrum Recent Developments
  49. 8.9 Cannabis Strategies Acquisition
  50. 8.9.1 Cannabis Strategies Acquisition Company Information
  51. 8.9.2 Cannabis Strategies Acquisition Business Overview
  52. 8.9.3 Cannabis Strategies Acquisition Pet Medical Cannabidiol Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Cannabis Strategies Acquisition Pet Medical Cannabidiol Product Portfolio
  54. 8.9.5 Cannabis Strategies Acquisition Recent Developments
  55. 8.10 Pet Releaf
  56. 8.10.1 Pet Releaf Company Information
  57. 8.10.2 Pet Releaf Business Overview
  58. 8.10.3 Pet Releaf Pet Medical Cannabidiol Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Pet Releaf Pet Medical Cannabidiol Product Portfolio
  60. 8.10.5 Pet Releaf Recent Developments
  61. 8.11 Diamond CBD
  62. 8.11.1 Diamond CBD Company Information
  63. 8.11.2 Diamond CBD Business Overview
  64. 8.11.3 Diamond CBD Pet Medical Cannabidiol Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Diamond CBD Pet Medical Cannabidiol Product Portfolio
  66. 8.11.5 Diamond CBD Recent Developments
  67. 8.12 PotNetwork Holdings
  68. 8.12.1 PotNetwork Holdings Company Information
  69. 8.12.2 PotNetwork Holdings Business Overview
  70. 8.12.3 PotNetwork Holdings Pet Medical Cannabidiol Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 PotNetwork Holdings Pet Medical Cannabidiol Product Portfolio
  72. 8.12.5 PotNetwork Holdings Recent Developments
  73. 8.13 Kat's Naturals
  74. 8.13.1 Kat's Naturals Company Information
  75. 8.13.2 Kat's Naturals Business Overview
  76. 8.13.3 Kat's Naturals Pet Medical Cannabidiol Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Kat's Naturals Pet Medical Cannabidiol Product Portfolio
  78. 8.13.5 Kat's Naturals Recent Developments
  79. 8.14 Bluebird Botanicals
  80. 8.14.1 Bluebird Botanicals Company Information
  81. 8.14.2 Bluebird Botanicals Business Overview
  82. 8.14.3 Bluebird Botanicals Pet Medical Cannabidiol Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bluebird Botanicals Pet Medical Cannabidiol Product Portfolio
  84. 8.14.5 Bluebird Botanicals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pet Medical Cannabidiol Value Chain Analysis
  2. 9.1.1 Pet Medical Cannabidiol Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pet Medical Cannabidiol Production Mode & Process
  6. 9.2 Pet Medical Cannabidiol Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pet Medical Cannabidiol Distributors
  9. 9.2.3 Pet Medical Cannabidiol Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst